Smart Immune treats adult acute leukemia patient at final dose level in Phase I/II ReSET-02 trial
May 2, 2024
40th annual J.P Morgan Healthcare conference: following our latest announcement on the launch of the T-cell progenitor-based platform, we are looking forward to meeting there and share our latest progress.